Contact Us | Home
Toll Free No. for USA/Canada:   1-866-279-8368
| Advance Search
Currency:  $ £
Discounted Reports
Energy & Resources
FMCG & Retailing
Pharmaceuticals and Healthcare

SYMBIO - Significant Upside still Remains: Bendamustine + Regosertib + Cash to In-license More!

Enquire | Email | Print

Published Date: Jan, 2013
Format: PDF
No of Pages: 5
Select pricing :
Change Currency: EURO | $ USD | £ GBP
Buy through us and save. We do not add any Tax / Duty including VAT,GST
  • Abstract
  • Table of Contents

PI3K inhibitors and clinical data of Bendamustine +other drugs in chronic lymphocytic leukemia (CLL) and other leukemias were the flavor at ASH ‘12 and at the 31st JP Morgan Healthcare conference. The positive impact of these was seen in the small cap Japanese company SymBio Pharma (4582) whose stock has gone up by ~185% since our initiation on September 14th 2012. SymBio’s focus on Japan and select Asia Pacific Rim countries market along with its pipeline makes it attractive to companies seeking presence in these geographies.

We currently attribute this impact to the investment it received from PE Whiz Partners in the form of convertible bonds and promising future potential of its product portfolio. For more details, please read our report released on 16th January. 2013 on SymBio titled “Significant Upside still Remains: Bendamustine + Regosertib + Cash to In-license More!”

Related Reports:  


Custom Research
If above report doesn't have the business information suitable for your business, we can provide custom research that would be lucrative for your business or enhance your profession. We leverage most comprehensive, affordable, high-quality custom research which will match exact topic & specifications of your choice. Please visit Custom Research page to make an enquiry.


Top Go to top of the page

product id: 371874, price: INR 5481, MP Advisors

International Travel Grant for Members of
MANLIBNET (Management Libraries Network)
We accept
Phone: +91.22.27810772, 27810773
Hours: Mon to Sat 8:00 AM to 8:00 PM IST
Call USA/Canada 1-866-279-8368
About Trust Online